Tirzepatide 30mg – Research Peptide

Tirzepatide 30mg research peptide is supplied as a high-purity lyophilized synthetic compound intended strictly for laboratory investigation of dual incretin receptor signaling pathways. In controlled research environments, this compound is evaluated for its interaction with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.

Read the full comparison here.

Research Applications

• Dual incretin receptor activation studies

• GLP-1 and GIP receptor pathway modeling

• cAMP signaling pathway analysis

• Metabolic system research frameworks

• Intracellular signaling cascade investigation

Tirzepatide’s dual-agonist structure differentiates it from triple-receptor research compounds evaluated in expanded metabolic pathway models.

Retatrutide

Product Specifications

• Compound: Tirzepatide

• Strength: 30mg per vial

• Form: Lyophilized powder

• Purity: Research-grade (see COA)

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis

Each vial includes a QR code linking to the current Certificate of Analysis for batch verification.

Current Active Batch: # ERL-2501-B020-T

View Current COA

Research Use Notice

This compound is supplied strictly for laboratory research use only. Not for human or animal consumption.

Related Metabolic Research Peptides

Researchers studying Tirzepatide may also examine:

• Retatrutide 20mg – Research Peptide

• AOD-9604 5mg – Research Peptide

• MOTS-C 10mg – Research Peptide